Dupont Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,867
| Closed | -$292K | – | 1253 |
|
|
2019
Q3 | $292K | Sell |
4,867
-8,610
| -64% | -$517K | 0.01% | 1008 |
|
|
2019
Q2 | $1.14M | Buy |
13,477
+1,174
| +10% | +$99K | 0.03% | 507 |
|
|
2019
Q1 | $1.18M | Hold |
12,303
| – | – | 0.03% | 505 |
|
|
2018
Q4 | $871K | Hold |
12,303
| – | – | 0.02% | 571 |
|
|
2018
Q3 | $1.05M | Hold |
12,303
| – | – | 0.02% | 554 |
|
|
2018
Q2 | $1.43M | Buy |
12,303
+5,668
| +85% | +$657K | 0.03% | 458 |
|
|
2018
Q1 | $537K | Hold |
6,635
| – | – | 0.01% | 662 |
|
|
2017
Q4 | $389K | Sell |
6,635
-9,598
| -59% | -$563K | 0.01% | 715 |
|
|
2017
Q3 | $760K | Hold |
16,233
| – | – | 0.02% | 582 |
|
|
2017
Q2 | $584K | Sell |
16,233
-13,866
| -46% | -$499K | 0.01% | 647 |
|
|
2017
Q1 | $927K | Hold |
30,099
| – | – | 0.02% | 541 |
|
|
2016
Q4 | $1.01M | Hold |
30,099
| – | – | 0.02% | 488 |
|
|
2016
Q3 | $801K | Buy |
+30,099
| New | +$801K | 0.02% | 502 |
|
|
2016
Q2 | – | Sell |
-13,128
| Closed | -$386K | – | 678 |
|
|
2016
Q1 | $386K | Hold |
13,128
| – | – | 0.01% | 573 |
|
|
2015
Q4 | $433K | Hold |
13,128
| – | – | 0.01% | 580 |
|
|
2015
Q3 | $474K | Hold |
13,128
| – | – | 0.01% | 542 |
|
|
2015
Q2 | $591K | Buy |
+13,128
| New | +$591K | 0.01% | 495 |
|